MC2 07Alternative Names: MC2-07
Latest Information Update: 18 Dec 2015
At a glance
- Originator Drug Delivery Solutions ApS
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 18 Dec 2015 Discontinued - Preclinical for Atopic dermatitis in Germany (Topical)
- 08 Oct 2014 Preclinical trials in Atopic dermatitis in Germany (Topical)